URBN
82
2
IR
65
-6
MMC
62
-5
NEE
54
-5
DLTR
44
-2
EQR
47
-6
INTC
36
-5
CPB
30
-9
FDX
30
-7
IP
67
2
SLG
55
-4
NWS
90
26
SYY
53
-3
SE
65
2
KMX
66
2
BF.B
35
-4
PSA
53
-7
PEG
62
-2
IVZ
52
-3
PRU
62
-2
URBN
82
2
IR
65
-6
MMC
62
-5
NEE
54
-5
DLTR
44
-2
EQR
47
-6
INTC
36
-5
CPB
30
-9
FDX
30
-7
IP
67
2
SLG
55
-4
NWS
90
26
SYY
53
-3
SE
65
2
KMX
66
2
BF.B
35
-4
PSA
53
-7
PEG
62
-2
IVZ
52
-3
PRU
62
-2
Financhill
Back

PTC Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
47

PTCT
PTC Therapeutics

Last Price:
49.88
Seasonality Move:
17.12%
Sell
30

ALNY
Alnylam Pharmaceuticals

Last Price:
254.05
Seasonality Move:
7.55%
Sell
47
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $251.84. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $50.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $251.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.11 Buy
Relative Strength Index (14 RSI): 66.75 Buy
Chaikin Money Flow: -849912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.04 - 46.16) Buy
Bollinger Bands (100): (32.47 - 41.53) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.1 Sell
Relative Strength Index (14 RSI): 43.24 Sell
Chaikin Money Flow: 214051 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (245.03 - 274.53) Sell
Bollinger Bands (100): (248.53 - 281.65) Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.81 Buy
20-day SMA: 43.67 Buy
50-day SMA: 40.62 Buy
200-day SMA: 34.19 Buy
8-day EMA: 46.55 Buy
20-day EMA: 44.07 Buy
50-day EMA: 41.1 Buy
200-day EMA: 35.83 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 250.96 Buy
20-day SMA: 255.88 Sell
50-day SMA: 270.14 Sell
200-day SMA: 214.29 Buy
8-day EMA: 251.71 Buy
20-day EMA: 256.34 Sell
50-day EMA: 262.6 Sell
200-day EMA: 232.29 Buy

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):